Cobenfy™ for the Treatment of Schizophrenia: A Clinical Overview.

IF 1.1 4区医学 Q3 NURSING

Journal of Psychosocial Nursing and Mental Health Services Pub Date : 2025-09-01 DOI:10.3928/02793695-20250811-02

Brayden Kameg, Josh Palmer, Tanner Herb

引用次数: 0

Abstract

Schizophrenia is a severe mental illness associated with significant psychosocial impairment, morbidity, and mortality. There are novel, emerging interventions in the treatment of schizophrenia, and advanced practice psychiatric nurses should be familiar with innovative treatments for schizophrenia. The current article provides a brief overview of xanomeline and trospium chloride (Cobenfy™) for the treatment of schizophrenia.

查看原文本刊更多论文

Cobenfy™用于治疗精神分裂症：临床概述。

精神分裂症是一种严重的精神疾病，与严重的社会心理障碍、发病率和死亡率相关。在精神分裂症的治疗中有新颖的、新兴的干预措施，高级精神科护士应该熟悉精神分裂症的创新治疗方法。目前的文章提供了xanomeline和trospium chloride （Cobenfy™）治疗精神分裂症的简要概述。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Psychosocial Nursing and Mental Health Services 医学-护理

CiteScore

1.60

自引率

0.00%

发文量

117

审稿时长

6-12 weeks

期刊介绍： The Journal of Psychosocial Nursing and Mental Health Services is a peer-reviewed, monthly journal for psychosocial and mental health nurses in a variety of community and institutional settings. For more than 50 years, the Journal has provided the most up-to-date, practical information available for today’s psychosocial-mental health nurse, including short contributions about psychopharmacology, mental health care of older adults, addictive behaviors and diagnoses, and child/adolescent disorders and issues. Begin to explore the Journal and all of its great benefits such as: • Monthly feature, “Clip & Save: Drug Chart,” a one-page resource of up-to-date information on current medications for various psychiatric illnesses • Access to current articles, as well as several years of archived content • Articles posted online just 2 months after acceptance • Continuing Nursing Education credits available each month